Search

Your search keyword '"Jung, Seungyoun"' showing total 191 results
Start Over Author "Jung, Seungyoun"
191 results on '"Jung, Seungyoun"'

6. Pubertal timing and breast density in young women: a prospective cohort study

Author

Houghton, Lauren C, Jung, Seungyoun, Troisi, Rebecca, LeBlanc, Erin S, Snetselaar, Linda G, Hylton, Nola M, Klifa, Catherine, Van Horn, Linda, Paris, Kenneth, Shepherd, John A, Hoover, Robert N, and Dorgan, Joanne F

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Breast Cancer, Cancer, Contraception/Reproduction, Clinical Research, Pediatric, Reproductive health and childbirth, Adolescent, Adult, Body Mass Index, Body Size, Breast, Breast Density, Breast Neoplasms, Child, Female, Humans, Magnetic Resonance Imaging, Menarche, Prospective Studies, Puberty, Risk Factors, Sexual Maturation, Time Factors, Breast cancer, Breast density, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

BACKGROUND:Earlier age at onset of pubertal events and longer intervals between them (tempo) have been associated with increased breast cancer risk. It is unknown whether the timing and tempo of puberty are associated with adult breast density, which could mediate the increased risk. METHODS:From 1988 to 1997, girls participating in the Dietary Intervention Study in Children (DISC) were clinically assessed annually between ages 8 and 17 years for Tanner stages of breast development (thelarche) and pubic hair (pubarche), and onset of menses (menarche) was self-reported. In 2006-2008, 182 participants then aged 25-29 years had their percent dense breast volume (%DBV) measured by magnetic resonance imaging. Multivariable, linear mixed-effects regression models adjusted for reproductive factors, demographics, and body size were used to evaluate associations of age and tempo of puberty events with %DBV. RESULTS:The mean (standard deviation) and range of %DBV were 27.6 (20.5) and 0.2-86.1. Age at thelarche was negatively associated with %DBV (p trend = 0.04), while pubertal tempo between thelarche and menarche was positively associated with %DBV (p trend = 0.007). %DBV was 40% higher in women whose thelarche-to-menarche tempo was 2.9 years or longer (geometric mean (95%CI) = 21.8% (18.2-26.2%)) compared to women whose thelarche-to-menarche tempo was less than 1.6 years (geometric mean (95%CI) = 15.6% (13.9-17.5%)). CONCLUSIONS:Our results suggest that a slower pubertal tempo, i.e., greater number of months between thelarche and menarche, is associated with higher percent breast density in young women. Future research should examine whether breast density mediates the association between slower tempo and increased breast cancer risk.

Published
2019

8. Intake of dietary carbohydrates in early adulthood and adolescence and breast density among young women

Author

Jung, Seungyoun, Goloubeva, Olga, Hylton, Nola, Klifa, Catherine, LeBlanc, Erin, Shepherd, John, Snetselaar, Linda, Van Horn, Linda, and Dorgan, Joanne F

Subjects
Biomedical and Clinical Sciences, Nutrition and Dietetics, Pediatric Research Initiative, Breast Cancer, Cancer, Clinical Research, Nutrition, Prevention, Pediatric, Adolescent, Adult, Breast Density, Breast Neoplasms, Child, Diet, Dietary Carbohydrates, Dietary Fiber, Female, Follow-Up Studies, Glycemic Index, Glycemic Load, Humans, Magnetic Resonance Imaging, Risk Factors, Carbohydrate, Fiber, Glycemic index, Glycemic load, Fructose, Sucrose, Breast density, Absolute dense reast volume, Absolute non-dense breast volume, Young women, Timing of exposure, Breast cancer, Absolute dense breast volume, Oncology and Carcinogenesis, Public Health and Health Services, Epidemiology, Oncology and carcinogenesis
Abstract

PurposeCarbohydrate intake increases postprandial insulin secretion and may affect breast density, a strong risk factor for breast cancer, early in life. We examined associations of adolescent and early adulthood intakes of total carbohydrates, glycemic index/load, fiber, and simple sugars with breast density among 182 young women.MethodsDiet was assessed using three 24-h recalls at each of five Dietary Intervention Study in Children (DISC) clinic visits when participants were age 10-19 years and at the DISC06 Follow-Up Study clinic visit when participants were age 25-29 years. Associations between energy-adjusted carbohydrates and MRI-measured percent dense breast volume (%DBV) and absolute dense breast volume (ADBV) at 25-29 years were quantified using multivariable-adjusted mixed-effects linear models.ResultsAdolescent sucrose intakes and premenarcheal total carbohydrates intakes were modestly associated with higher %DBV (mean %DBVQ1 vs Q4, 16.6 vs 23.5% for sucrose; and 17.2 vs 22.3% for premenarcheal total carbohydrates, all Ptrend ≤ 0.02), but not with ADBV. However, adolescent intakes of fiber and fructose were not associated with %DBV and ADBV. Early adulthood intakes of total carbohydrates, glycemic index/load, fiber, and simple sugars were not associated with %DBV and ADBV.ConclusionsInsulinemic carbohydrate diet during puberty may be associated with adulthood breast density, but our findings need replication in larger studies. Clinical Trials Registration ClinicalTrials.gov Identifier, NCT00458588 April 9, 2007; NCT00000459 October 27, 1999.

Published
2018

24. A comparison of associations of body mass index and dual‐energy x‐ray absorptiometry measured percentage fat and total fat with global serum metabolites in young women

Author

Dorgan, Joanne F., primary, Ryan, Alice S., additional, LeBlanc, Erin S., additional, Van Horn, Linda, additional, Magder, Laurence S., additional, Snetselaar, Linda G., additional, Zhang, Yuji, additional, Dallal, Cher M., additional, Jung, Seungyoun, additional, and Shepherd, John A., additional

Published
2023
Full Text
View/download PDF

25. Anti‐Müllerian hormone and risk of ovarian cancer in nine cohorts

Author

Jung, Seungyoun, Allen, Naomi, Arslan, Alan A., Baglietto, Laura, Barricarte, Aurelio, Brinton, Louise A., Egleston, Brian L., Falk, Roni T., Fortner, Renée T., Helzlsouer, Kathy J., Gao, Yutang, Idahl, Annika, Kaaks, Rudolph, Krogh, Vittorio, Merritt, Melissa A., Lundin, Eva, Onland‐Moret, N. Charlotte, Rinaldi, Sabina, Schock, Helena, Shu, Xiao‐Ou, Sluss, Patrick M., Staats, Paul N., Sacerdote, Carlotta, Travis, Ruth C., Tjønneland, Anne, Trichopoulou, Antonia, Tworoger, Shelley S., Visvanathan, Kala, Weiderpass, Elisabete, Zeleniuch‐Jacquotte, Anne, and Dorgan, Joanne F.

Published
2018
Full Text
View/download PDF

27. Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status

Author

Inamura, Kentaro, Song, Mingyang, Jung, Seungyoun, Nishihara, Reiko, Yamauchi, Mai, Lochhead, Paul, Qian, Zhi Rong, Kim, Sun A., Mima, Kosuke, Sukawa, Yasutaka, Masuda, Atsuhiro, Imamura, Yu, Zhang, Xuehong, Pollak, Michael N., Mantzoros, Christos S., Harris, Curtis C., Giovannucci, Edward, Fuchs, Charles S., Cho, Eunyoung, Chan, Andrew T., Wu, Kana, and Ogino, Shuji

Published
2016
Full Text
View/download PDF

30. Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies

Author

Zhang, Xuehong, Spiegelman, Donna, Baglietto, Laura, Bernstein, Leslie, Boggs, Deborah A, van den Brandt, Piet A, Buring, Julie E, Gapstur, Susan M, Giles, Graham G, Giovannucci, Edward, Goodman, Gary, Hankinson, Susan E, Helzlsouer, Kathy J, Horn-Ross, Pamela L, Inoue, Manami, Jung, Seungyoun, Khudyakov, Polyna, Larsson, Susanna C, Lof, Marie, McCullough, Marjorie L, Miller, Anthony B, Neuhouser, Marian L, Palmer, Julie R, Park, Yikyung, Robien, Kim, Rohan, Thomas E, Ross, Julie A, Schouten, Leo J, Shikany, James M, Tsugane, Shoichiro, Visvanathan, Kala, Weiderpass, Elisabete, Wolk, Alicja, Willett, Walter C, Zhang, Shumin M, Ziegler, Regina G, and Smith-Warner, Stephanie A

Published
2012
Full Text
View/download PDF

36. Fruit and Vegetable Intake and Risk of Breast Cancer by Hormone Receptor Status

Author

Jung, Seungyoun, Spiegelman, Donna, Baglietto, Laura, Bernstein, Leslie, Boggs, Deborah A., van den Brandt, Piet A., Buring, Julie E., Cerhan, James R., Gaudet, Mia M., Giles, Graham G., Goodman, Gary, Hakansson, Niclas, Hankinson, Susan E., Helzlsouer, Kathy, Horn-Ross, Pamela L., Inoue, Manami, Krogh, Vittorio, Lof, Marie, McCullough, Marjorie L., Miller, Anthony B., Neuhouser, Marian L., Palmer, Julie R., Park, Yikyung, Robien, Kim, Rohan, Thomas E., Scarmo, Stephanie, Schairer, Catherine, Schouten, Leo J., Shikany, James M., Sieri, Sabina, Tsugane, Schoichiro, Visvanathan, Kala, Weiderpass, Elisabete, Willett, Walter C., Wolk, Alicja, Zeleniuch-Jacquotte, Anne, Zhang, Shumin M., Zhang, Xuehong, Ziegler, Regina G., and Smith-Warner, Stephanie A.

Published
2013
Full Text
View/download PDF

40. Anti-Mullerian hormone and risk of ovarian cancer in nine cohorts

Author

Jung, Seungyoun Allen, Naomi Arslan, Alan A. Baglietto, Laura Barricarte, Aurelio Brinton, Louise A. Egleston, Brian L. Falk, Roni T. Fortner, Renee T. Helzlsouer, Kathy J. and Gao, Yutang Idahl, Annika Kaaks, Rudolph Krogh, Vittorio and Merritt, Melissa A. Lundin, Eva Onland-Moret, N. Charlotte and Rinaldi, Sabina Schock, Helena Shu, Xiao-Ou Sluss, Patrick M. Staats, Paul N. Sacerdote, Carlotta Travis, Ruth C. and Tjonneland, Anne Trichopoulou, Antonia Tworoger, Shelley S. and Visvanathan, Kala Weiderpass, Elisabete Zeleniuch-Jacquotte, Anne Dorgan, Joanne F.

Subjects
endocrine system, endocrine system diseases, female genital diseases and pregnancy complications
Abstract

Animal and experimental data suggest that anti-Mullerian hormone (AMH) serves as a marker of ovarian reserve and inhibits the growth of ovarian tumors. However, few epidemiologic studies have examined the association between AMH and ovarian cancer risk. We conducted a nested case-control study of 302 ovarian cancer cases and 336 matched controls from nine cohorts. Prediagnostic blood samples of premenopausal women were assayed for AMH using a picoAMH enzyme-linked immunosorbent assay. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using multivariable-adjusted conditional logistic regression. AMH concentration was not associated with overall ovarian cancer risk. The multivariable-adjusted OR (95% CI), comparing the highest to the lowest quartile of AMH, was 0.99 (0.59-1.67) (P-trend: 0.91). The association did not differ by age at blood draw or oral contraceptive use (all P-heterogeneity: >= 0.26). There also was no evidence for heterogeneity of risk for tumors defined by histologic developmental pathway, stage, and grade, and by age at diagnosis and time between blood draw and diagnosis (all P-heterogeneity: >= 0.39). In conclusion, this analysis of mostly late premenopausal women from nine cohorts does not support the hypothesized inverse association between prediagnostic circulating levels of AMH and risk of ovarian cancer.

Published
2018

41. Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts

Author

Cardiovasculaire Epi Team 3, Cancer, JC onderzoeksprogramma Kanker, Jung, Seungyoun, Allen, Naomi E., Arslan, Alan A, Baglietto, Laura, Barricarte, Aurelio, Brinton, Louise A, Egleston, Brian L., Falk, Roni T, Turzanski-Fortner, Renée, Helzlsouer, Kathy J, Gao, Yutang, Idahl, Annika, Kaaks, Rudolph, Krogh, Vittorio, Merritt, Melissa A., Lundin, Eva, Onland-Moret, N Charlotte, Rinaldi, Sabina, Schock, Helena, Shu, Xiao Ou, Sluss, Patrick M., Staats, Paul N., Sacerdote, Carlotta, Travis, Ruth C., Tjønneland, Anne, Trichopoulou, Antonia, Tworoger, Shelley S., Visvanathan, Kala, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Dorgan, Joanne F., Cardiovasculaire Epi Team 3, Cancer, JC onderzoeksprogramma Kanker, Jung, Seungyoun, Allen, Naomi E., Arslan, Alan A, Baglietto, Laura, Barricarte, Aurelio, Brinton, Louise A, Egleston, Brian L., Falk, Roni T, Turzanski-Fortner, Renée, Helzlsouer, Kathy J, Gao, Yutang, Idahl, Annika, Kaaks, Rudolph, Krogh, Vittorio, Merritt, Melissa A., Lundin, Eva, Onland-Moret, N Charlotte, Rinaldi, Sabina, Schock, Helena, Shu, Xiao Ou, Sluss, Patrick M., Staats, Paul N., Sacerdote, Carlotta, Travis, Ruth C., Tjønneland, Anne, Trichopoulou, Antonia, Tworoger, Shelley S., Visvanathan, Kala, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, and Dorgan, Joanne F.

Published
2018

42. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour

Author

Hamada, Tsuyoshi, primary, Liu, Li, additional, Nowak, Jonathan A., additional, Mima, Kosuke, additional, Cao, Yin, additional, Ng, Kimmie, additional, Twombly, Tyler S., additional, Song, Mingyang, additional, Jung, Seungyoun, additional, Dou, Ruoxu, additional, Masugi, Yohei, additional, Kosumi, Keisuke, additional, Shi, Yan, additional, da Silva, Annacarolina, additional, Gu, Mancang, additional, Li, Wanwan, additional, Keum, NaNa, additional, Wu, Kana, additional, Nosho, Katsuhiko, additional, Inamura, Kentaro, additional, Meyerhardt, Jeffrey A., additional, Nevo, Daniel, additional, Wang, Molin, additional, Giannakis, Marios, additional, Chan, Andrew T., additional, Giovannucci, Edward L., additional, Fuchs, Charles S., additional, Nishihara, Reiko, additional, Zhang, Xuehong, additional, and Ogino, Shuji, additional

Published
2018
Full Text
View/download PDF

43. Anti-Mullerian hormone and endometrial cancer : a multi-cohort study

Author

Fortner, Renée T., Schock, Helena, Jung, Seungyoun, Allen, Naomi E., Arslan, Alan A., Brinton, Louise A., Egleston, Brian L., Falk, Roni T., Gunter, Marc J., Helzlsouer, Kathy J., Idahl, Annika, Johnson, Theron S., Kaaks, Rudolf, Krogh, Vittorio, Lundin, Eva, Merritt, Melissa A., Navarro, Carmen, Onland-Moret, N. Charlotte, Palli, Domenico, Shu, Xiao-Ou, Sluss, Patrick M., Staats, Paul N., Trichopoulou, Antonia, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, Dorgan, Joanne F., Fortner, Renée T., Schock, Helena, Jung, Seungyoun, Allen, Naomi E., Arslan, Alan A., Brinton, Louise A., Egleston, Brian L., Falk, Roni T., Gunter, Marc J., Helzlsouer, Kathy J., Idahl, Annika, Johnson, Theron S., Kaaks, Rudolf, Krogh, Vittorio, Lundin, Eva, Merritt, Melissa A., Navarro, Carmen, Onland-Moret, N. Charlotte, Palli, Domenico, Shu, Xiao-Ou, Sluss, Patrick M., Staats, Paul N., Trichopoulou, Antonia, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, and Dorgan, Joanne F.

Abstract

Background: The Mullerian ducts are the embryological precursors of the female reproductive tract, including the uterus; anti-Mullerian hormone (AMH) has a key role in the regulation of foetal sexual differentiation. Anti-Mullerian hormone inhibits endometrial tumour growth in experimental models by stimulating apoptosis and cell cycle arrest. To date, there are no prospective epidemiologic data on circulating AMH and endometrial cancer risk. Methods: We investigated this association among women premenopausal at blood collection in a multicohort study including participants from eight studies located in the United States, Europe, and China. We identified 329 endometrial cancer cases and 339 matched controls. AntiMullerian hormone concentrations in blood were quantified using an enzyme-linked immunosorbent assay. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CI) across tertiles and for a doubling of AMH concentrations (ORlog2). Subgroup analyses were performed by ages at blood donation and diagnosis, oral contraceptive use, and tumour characteristics. Results: Anti-Mullerian hormone was not associated with the risk of endometrial cancer overall (ORlog(2): 1.07 (0.99-1.17)), or with any of the examined subgroups. Conclusions: Although experimental models implicate AMH in endometrial cancer growth inhibition, our findings do not support a role for circulating AMH in the aetiology of endometrial cancer.

Published
2017
Full Text
View/download PDF

44. Demographic, lifestyle, and other factors in relation to antimullerian hormone levels in mostly late premenopausal women

Author

Jung, Seungyoun, Allen, Naomi, Arslan, Alan A., Baglietto, Laura, Brinton, Louise A., Egleston, Brian L., Falk, Roni, Fortner, Renee T., Helzlsouer, Kathy J., Idahl, Annika, Kaaks, Rudolph, Lundin, Eva, Merritt, Melissa, Onland-Moret, Charlotte, Rinaldi, Sabina, Sanchez, Maria-Jose, Sieri, Sabina, Schock, Helena, Shu, Xiao-Ou, Sluss, Patrick M., Staats, Paul N., Travis, Ruth C., Tjonneland, Anne, Trichopoulou, Antonia, Tworoger, Shelley, Visvanathan, Kala, Krogh, Vittorio, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, Dorgan, Joanne F., Jung, Seungyoun, Allen, Naomi, Arslan, Alan A., Baglietto, Laura, Brinton, Louise A., Egleston, Brian L., Falk, Roni, Fortner, Renee T., Helzlsouer, Kathy J., Idahl, Annika, Kaaks, Rudolph, Lundin, Eva, Merritt, Melissa, Onland-Moret, Charlotte, Rinaldi, Sabina, Sanchez, Maria-Jose, Sieri, Sabina, Schock, Helena, Shu, Xiao-Ou, Sluss, Patrick M., Staats, Paul N., Travis, Ruth C., Tjonneland, Anne, Trichopoulou, Antonia, Tworoger, Shelley, Visvanathan, Kala, Krogh, Vittorio, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, and Dorgan, Joanne F.

Abstract

Objective: To identify reproductive, lifestyle, hormonal, and other correlates of circulating antimullerian hormone (AMH) concentrations in mostly late premenopausal women. Design: Cross-sectional study. Setting: Not applicable. Patient(s): A total of 671 premenopausal women not known to have cancer. Intervention(s): None. Main Outcome Measure(s): Concentrations of AMH were measured in a single laboratory using the picoAMH ELISA. Multivariable-adjusted median (and interquartile range) AMH concentrations were calculated using quantile regression for several potential correlates. Result(s): Older women had significantly lower AMH concentrations (>= 40 [n = 444] vs. < 35 years [n = 64], multivariable-adjusted median 0.73 ng/mL vs. 2.52 ng/mL). Concentrations of AMH were also significantly lower among women with earlier age at menarche (< 12 [n = 96] vs. >= 14 years [n = 200]: 0.90 ng/mL vs. 1.12 ng/mL) and among current users of oral contraceptives (n = 27) compared with never or former users (n = 468) (0.36 ng/mL vs. 1.15 ng/mL). Race, body mass index, education, height, smoking status, parity, and menstrual cycle phase were not significantly associated with AMH concentrations. There were no significant associations between AMH concentrations and androgen or sex hormone-binding globulin concentrations or with factors related to blood collection (e.g., sample type, time, season, and year of blood collection). Conclusion(s): Among premenopausal women, lower AMH concentrations are associated with older age, a younger age at menarche, and currently using oral contraceptives, suggesting these factors are related to a lower number or decreased secretory activity of ovarian follicles.

Published
2017
Full Text
View/download PDF

45. Anti-Mullerian hormone and endometrial cancer : a multi-cohort study

Author

Turzanski-Fortner, Renée, Schock, Helena, Jung, Seungyoun, Allen, Naomi E., Arslan, Alan A, Brinton, Louise A, Egleston, Brian L., Falk, Roni T, Gunter, Marc J., Helzlsouer, Kathy J, Idahl, Annika, Johnson, Theron S, Kaaks, Rudolf, Krogh, Vittorio, Lundin, Eva, Merritt, Melissa A., Navarro, Carmen, Onland-Moret, N Charlotte, Palli, Domenico, Shu, Xiao Ou, Sluss, Patrick M., Staats, Paul N., Trichopoulou, Antonia, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, Dorgan, Joanne F., Turzanski-Fortner, Renée, Schock, Helena, Jung, Seungyoun, Allen, Naomi E., Arslan, Alan A, Brinton, Louise A, Egleston, Brian L., Falk, Roni T, Gunter, Marc J., Helzlsouer, Kathy J, Idahl, Annika, Johnson, Theron S, Kaaks, Rudolf, Krogh, Vittorio, Lundin, Eva, Merritt, Melissa A., Navarro, Carmen, Onland-Moret, N Charlotte, Palli, Domenico, Shu, Xiao Ou, Sluss, Patrick M., Staats, Paul N., Trichopoulou, Antonia, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, and Dorgan, Joanne F.

Published
2017

46. Anti-Mullerian hormone and endometrial cancer: a multi-cohort study

Author

Cardiovasculaire Epi Team 3, Brain, Cancer, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, JC onderzoeksprogramma Kanker, Turzanski-Fortner, Renée, Schock, Helena, Jung, Seungyoun, Allen, Naomi E., Arslan, Alan A, Brinton, Louise A, Egleston, Brian L., Falk, Roni T, Gunter, Marc J., Helzlsouer, Kathy J, Idahl, Annika, Johnson, Theron S, Kaaks, Rudolf, Krogh, Vittorio, Lundin, Eva, Merritt, Melissa A., Navarro, Carmen, Onland-Moret, N Charlotte, Palli, Domenico, Shu, Xiao Ou, Sluss, Patrick M., Staats, Paul N., Trichopoulou, Antonia, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, Dorgan, Joanne F., Cardiovasculaire Epi Team 3, Brain, Cancer, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, JC onderzoeksprogramma Kanker, Turzanski-Fortner, Renée, Schock, Helena, Jung, Seungyoun, Allen, Naomi E., Arslan, Alan A, Brinton, Louise A, Egleston, Brian L., Falk, Roni T, Gunter, Marc J., Helzlsouer, Kathy J, Idahl, Annika, Johnson, Theron S, Kaaks, Rudolf, Krogh, Vittorio, Lundin, Eva, Merritt, Melissa A., Navarro, Carmen, Onland-Moret, N Charlotte, Palli, Domenico, Shu, Xiao Ou, Sluss, Patrick M., Staats, Paul N., Trichopoulou, Antonia, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, and Dorgan, Joanne F.

Published
2017

47. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women

Author

Epidemiology & Health Economics, Brain, Circulatory Health, Cancer, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, JC onderzoeksprogramma Kanker, Jung, Seungyoun, Allen, Naomi, Arslan, Alan A., Baglietto, Laura, Brinton, Louise A., Egleston, Brian L., Falk, Roni, Fortner, Renée T., Helzlsouer, Kathy J., Idahl, Annika, Kaaks, Rudolph, Lundin, Eva, Merritt, Melissa, Onland-Moret, Charlotte, Rinaldi, Sabina, Sánchez, María José, Sieri, Sabina, Schock, Helena, Shu, Xiao Ou, Sluss, Patrick M., Staats, Paul N., Travis, Ruth C., Tjønneland, Anne, Trichopoulou, Antonia, Tworoger, Shelley, Visvanathan, Kala, Krogh, Vittorio, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, Dorgan, Joanne F., Epidemiology & Health Economics, Brain, Circulatory Health, Cancer, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, JC onderzoeksprogramma Kanker, Jung, Seungyoun, Allen, Naomi, Arslan, Alan A., Baglietto, Laura, Brinton, Louise A., Egleston, Brian L., Falk, Roni, Fortner, Renée T., Helzlsouer, Kathy J., Idahl, Annika, Kaaks, Rudolph, Lundin, Eva, Merritt, Melissa, Onland-Moret, Charlotte, Rinaldi, Sabina, Sánchez, María José, Sieri, Sabina, Schock, Helena, Shu, Xiao Ou, Sluss, Patrick M., Staats, Paul N., Travis, Ruth C., Tjønneland, Anne, Trichopoulou, Antonia, Tworoger, Shelley, Visvanathan, Kala, Krogh, Vittorio, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, and Dorgan, Joanne F.

Published
2017

48. Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts

Author

Jung, Seungyoun, primary, Allen, Naomi, additional, Arslan, Alan A., additional, Baglietto, Laura, additional, Barricarte, Aurelio, additional, Brinton, Louise A., additional, Egleston, Brian L., additional, Falk, Roni T., additional, Fortner, Renée T., additional, Helzlsouer, Kathy J., additional, Gao, Yutang, additional, Idahl, Annika, additional, Kaaks, Rudolph, additional, Krogh, Vittorio, additional, Merritt, Melissa A., additional, Lundin, Eva, additional, Onland-Moret, N. Charlotte, additional, Rinaldi, Sabina, additional, Schock, Helena, additional, Shu, Xiao-Ou, additional, Sluss, Patrick M., additional, Staats, Paul N., additional, Sacerdote, Carlotta, additional, Travis, Ruth C., additional, Tjønneland, Anne, additional, Trichopoulou, Antonia, additional, Tworoger, Shelley S., additional, Visvanathan, Kala, additional, Weiderpass, Elisabete, additional, Zeleniuch-Jacquotte, Anne, additional, and Dorgan, Joanne F., additional

Published
2017
Full Text
View/download PDF

49. Anti-Mullerian hormone and endometrial cancer: a multi-cohort study

Author

Fortner, Renée T, primary, Schock, Helena, additional, Jung, Seungyoun, additional, Allen, Naomi E, additional, Arslan, Alan A, additional, Brinton, Louise A, additional, Egleston, Brian L, additional, Falk, Roni T, additional, Gunter, Marc J, additional, Helzlsouer, Kathy J, additional, Idahl, Annika, additional, Johnson, Theron S, additional, Kaaks, Rudolf, additional, Krogh, Vittorio, additional, Lundin, Eva, additional, Merritt, Melissa A, additional, Navarro, Carmen, additional, Onland-Moret, N Charlotte, additional, Palli, Domenico, additional, Shu, Xiao-Ou, additional, Sluss, Patrick M, additional, Staats, Paul N, additional, Trichopoulou, Antonia, additional, Weiderpass, Elisabete, additional, Zeleniuch-Jacquotte, Anne, additional, Zheng, Wei, additional, and Dorgan, Joanne F, additional

Published
2017
Full Text
View/download PDF

50. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women

Author

Jung, Seungyoun, primary, Allen, Naomi, additional, Arslan, Alan A., additional, Baglietto, Laura, additional, Brinton, Louise A., additional, Egleston, Brian L., additional, Falk, Roni, additional, Fortner, Renée T., additional, Helzlsouer, Kathy J., additional, Idahl, Annika, additional, Kaaks, Rudolph, additional, Lundin, Eva, additional, Merritt, Melissa, additional, Onland-Moret, Charlotte, additional, Rinaldi, Sabina, additional, Sánchez, María-José, additional, Sieri, Sabina, additional, Schock, Helena, additional, Shu, Xiao-Ou, additional, Sluss, Patrick M., additional, Staats, Paul N., additional, Travis, Ruth C., additional, Tjønneland, Anne, additional, Trichopoulou, Antonia, additional, Tworoger, Shelley, additional, Visvanathan, Kala, additional, Krogh, Vittorio, additional, Weiderpass, Elisabete, additional, Zeleniuch-Jacquotte, Anne, additional, Zheng, Wei, additional, and Dorgan, Joanne F., additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results